(Q61979804)
Statements
UPFRONT (English)
0 references
Randomized Phase 3b Study of Three Treatment Regimens in Subjects With Previously Untreated Multiple Myeloma Who Are Not Considered Candidates for High-Dose Chemotherapy and Autologous Stem Cell Transplantation: VELCADE, Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone (English)
0 references
June 2007
0 references
March 2013
0 references
502
0 references
18 year
0 references